SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

BOREA, Pier Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 52.289
AS - Asia 29.608
EU - Europa 20.136
SA - Sud America 4.430
AF - Africa 615
OC - Oceania 55
Continente sconosciuto - Info sul continente non disponibili 32
Totale 107.165
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 51.223
SG - Singapore 10.567
CN - Cina 7.731
DE - Germania 3.708
IT - Italia 3.698
BR - Brasile 3.419
VN - Vietnam 3.186
FI - Finlandia 3.105
UA - Ucraina 3.090
HK - Hong Kong 2.470
TR - Turchia 2.383
GB - Regno Unito 1.726
SE - Svezia 1.146
FR - Francia 1.133
RU - Federazione Russa 922
JP - Giappone 641
BD - Bangladesh 618
IN - India 603
CA - Canada 491
PL - Polonia 464
MX - Messico 430
AR - Argentina 375
NL - Olanda 298
ZA - Sudafrica 236
ID - Indonesia 231
IQ - Iraq 195
ES - Italia 173
EC - Ecuador 156
CO - Colombia 145
BE - Belgio 142
PK - Pakistan 126
VE - Venezuela 107
UZ - Uzbekistan 98
LT - Lituania 94
SA - Arabia Saudita 87
MA - Marocco 84
CL - Cile 83
CZ - Repubblica Ceca 82
MY - Malesia 78
PH - Filippine 78
TN - Tunisia 78
AT - Austria 75
AE - Emirati Arabi Uniti 72
PY - Paraguay 60
KE - Kenya 50
JO - Giordania 45
AU - Australia 44
EG - Egitto 41
IR - Iran 40
IE - Irlanda 37
KR - Corea 37
IL - Israele 36
NP - Nepal 30
DZ - Algeria 29
RO - Romania 29
UY - Uruguay 28
CR - Costa Rica 27
TW - Taiwan 27
PE - Perù 26
AZ - Azerbaigian 25
BO - Bolivia 24
AL - Albania 23
PT - Portogallo 23
CH - Svizzera 22
JM - Giamaica 22
KZ - Kazakistan 22
EU - Europa 21
ET - Etiopia 20
PS - Palestinian Territory 20
TH - Thailandia 20
OM - Oman 18
BG - Bulgaria 16
LB - Libano 16
HN - Honduras 15
SN - Senegal 15
KG - Kirghizistan 14
RS - Serbia 14
BH - Bahrain 13
PA - Panama 13
QA - Qatar 13
SY - Repubblica araba siriana 13
DO - Repubblica Dominicana 12
GR - Grecia 11
LV - Lettonia 11
MD - Moldavia 11
NO - Norvegia 11
BY - Bielorussia 10
HR - Croazia 10
HU - Ungheria 10
SV - El Salvador 10
AM - Armenia 9
NI - Nicaragua 9
NZ - Nuova Zelanda 9
AO - Angola 8
CI - Costa d'Avorio 8
GT - Guatemala 8
XK - ???statistics.table.value.countryCode.XK??? 8
BA - Bosnia-Erzegovina 7
CG - Congo 7
KH - Cambogia 7
Totale 107.011
Salva come PNG Salva come JPEG
Città #
Singapore 6.906
Ashburn 5.233
Woodbridge 4.579
Fairfield 3.675
San Jose 3.364
Jacksonville 3.300
Chandler 2.910
Houston 2.895
Hong Kong 2.419
Ann Arbor 2.405
Helsinki 2.277
Santa Clara 2.207
Beijing 2.159
Wilmington 1.660
Seattle 1.551
Dallas 1.539
Cambridge 1.158
Izmir 1.123
Ho Chi Minh City 1.072
Nanjing 1.020
Los Angeles 840
Hanoi 773
Princeton 712
Tokyo 621
New York 612
Lauterbourg 559
Boardman 530
Munich 527
Ferrara 457
Milan 452
Warsaw 401
San Diego 351
São Paulo 324
Nanchang 323
Shanghai 319
Shenyang 306
Council Bluffs 293
Falkenstein 290
Mexico City 264
Hefei 243
Orem 227
Tianjin 221
London 207
Hebei 204
Dearborn 203
Turku 194
Changsha 189
Buffalo 184
Bremen 183
Chicago 180
Frankfurt am Main 176
San Mateo 176
Addison 170
Jiaxing 169
The Dalles 169
Da Nang 155
Montreal 149
Chennai 141
Rome 141
Brooklyn 140
Brussels 137
Jinan 128
Haiphong 127
Toronto 118
Amsterdam 117
Johannesburg 117
Denver 116
Jakarta 116
Falls Church 115
Zhengzhou 112
Rio de Janeiro 111
San Francisco 109
Manchester 101
Moscow 101
Atlanta 100
Kunming 99
Phoenix 99
Guangzhou 98
Norwalk 95
Auburn Hills 94
Stockholm 89
Tashkent 88
Philadelphia 86
Bologna 85
Mountain View 85
Baghdad 80
Ningbo 80
Florence 78
Poplar 78
Boston 75
Mumbai 73
Belo Horizonte 67
Ankara 64
Biên Hòa 63
Düsseldorf 63
Orange 63
Redwood City 63
Hải Dương 58
Verona 58
Des Moines 56
Totale 69.889
Salva come PNG Salva come JPEG
Nome #
1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists 3.095
Farmacologia cellulare e molecolare, sistemi di trasmissione e autacoidi. Trasmissione purinergica 1.413
Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on “tetrad”, sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies 414
Pharmacology of Adenosine Receptors: The State of the Art 399
Progetto ex 60%- I recettori dell’adenosina come possibili “biomarkers” dei tumori colorettali. Studio su tessuti umani sani e tumorali e sulle cellule del sangue periferico. 398
Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor Antagonists 329
A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy 315
A glance at adenosine receptors: Novel target for antitumor therapy 308
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety 302
Synthesis and Structure Activity Relationship Investigation of Triazolo[1,5-a]pyrimidines as CB2 Cannabinoid Receptor Inverse Agonists 299
Alterazioni dei recettori alfa(2) adrenergici delle piastrine umane nell'ipertensione essenziale 298
Psychostimulant effect of the synthetic cannabinoid JWH-018 and AKB48. Behavioural, neurochemical and Dopamine transporter scan imaging studies in mice 297
Inhibition of A2A Adenosine Receptor Signaling in Cancer Cells Proliferation by the Novel Antagonist TP455 289
The A3 adenosine receptor: history and perspectives 285
Effect of JWH-250, JWH-073 and their interaction on “tetrad”, sensorimotor, neurological and neurochemical responses in mice 284
A(2B) adenosine receptors stimulate IL-6 production in primary murine microglia through p38 MAPK kinase pathway 284
Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptor 277
2-Arylpyrazolo[4,3-d]pyrimidin-7-amino derivatives as new potent and selective human A3 adenosine receptor antagonists. Molecular modeling studies and pharmacological evaluation 275
Recettori e trasduzione del segnale 270
Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron-Like and Microglial Cells 264
Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects? 263
Characterization of adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes exposed to low frequency low energy pulsed electromagnetic fields 261
Human vascular kinin receptors of the B-2 type characterized by radioligand binding 261
A2A and A3 adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase release 260
Recettori e trasduzione del segnale 257
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 257
7-Chloro-2,3-dihydro-1-methyl-5-phenyl-1H-1,4-benzodiazepine (medazepam) 256
Adenosine analogs and electromagnetic fields inhibit prostaglandin E2 release in bovine synovial fibroblasts 256
Adenosine receptors and human melanoma 255
7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as Selective CB2 Cannabinoid Receptor Ligands: Structural Investigations around a Novel Class of Full Agonists 253
[H-3]-MRE 2029-F20, a selective antagonist radioligand for the human A(2B) adenosine receptors 250
New 2-heterocyclyl-imidazo[2,1- i ]purin-5-one derivatives as potent and selective human A 3 adenosine receptor antagonists 246
Effects of two-carbon bridge region methoxylation of benztropine: discovery of novel chiral ligands for the dopamine transporter 245
[H-3]MRE 3008F20: A novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors 245
6-Amino-2-mercapto-3H-pyrimidin-4-one derivatives as new candidates for the antagonism at the P2Y12 receptors 244
Expression and functional role of adenosine receptors in regulating inflammatory responses in human synoviocytes. 244
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 243
N-6-[(Hetero)aryl/(cyclo)alkyl-carbamoyi-methoxy-phenyl]-(2chloro)-5 '-N-ethylearboxamido-adenosines: The first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor 242
Role and function of A2A and A3 adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis 242
New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2. 241
Pyrazolo [4,3-e][1,2,4]triazolo[1,5-c]pyrimidine template: Organic and medicinal chemistry approach 240
Ala scan analogues of HOE 140. Synthesis and biological activities 239
A(2A) adenosine receptors are up-regulated in lymphocytes from amyotrophic lateral sclerosis patients 238
Alteration of A3 adenosine receptors in human neutrophils and low frequency electromagnetic fields 237
Pharmaco-toxicological effects of the novel third-generation fluorinate synthetic cannabinoids, 5F-ADBINACA, AB-FUBINACA, and STS-135 in mice. In vitro and in vivo studies 237
History and perspectives of A2A adenosine receptor antagonists as potential therapeutic agents 236
Adenosine A1 receptors in the rat brain in the kindling model of epilepsy 236
Deficiency of polycystin-2 reduces Ca2+ channel activity and cell proliferation in ADPKD lymphoblastoid cells 236
Multiple sclerosis lymphocytes upregulate A(2A) adenosine receptors that are antiinflammatory when stimulated 234
Cannabinoid CB2 receptor attenuates morphine-induced inflammatory responses in activated microglial cells 234
Comparison of prazosin, terazosin and tamsulosin: Functional and binding studies in isolated prostatic and vascular human tissues 232
2 Aralkynyl and 2-heteroalkynyl derivatives of adenosine 5'-N-ethyluronamide as selective A2A adenosine receptor agonists 230
Adenosine modulates vascular endothelial growth factor expression via hypoxiainducible factor-1 in human glioblastoma cells. 228
The activation of μ-opioid receptor potentiates LPS-induced NF-kB promoting an inflammatory phenotype in microglia 228
From tyrosine to glycine: Synthesis and biological activity of potent antagonists of the purinergic P2X(7) receptor 226
Adenosine Receptor Antagonists: Translating Medicinal Chemistry and Pharmacology into Clinical Utility 226
Adenosine signaling contributes to ethanol-induced fatty liver in mice 226
7-nitro-1,3-dihydro-5-phenyl-1,4-benzodiazepin-2-one (nitrazepam) 226
Octadecyl, phenyl and cyano phases comparison for the RP-HPLC prediction of octanol-water partition coefficient 225
One-pot reaction to obtain N,N'-disubstituted guanidines of pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold as human A3 adenosine receptor antagonists 225
5-heteroarylcarbamoylamino-pyrazolo-triazolo pyrimidines as hA3 adenosine receptor antagonists. 224
Adenosine receptors and cancer 224
HIF-1 neuroprotection through erythropoietin increase in hypoxia: a role for A1 adenosine receptors 224
Adenosine receptor targeting in health and disease 223
A3 Receptors are Overexpressed in Pleura from Mesothelioma Patients and Reduce Cell Growth via Akt/NF-kB Pathway. 222
Design, Synthesis, and Pharmacological Characterization of 2-(2-Furanyl)thiazolo[5,4-d]pyrimidine-5,7-diamine Derivatives: New Highly Potent A2A Adenosine Receptor Inverse Agonists with Antinociceptive Activity 222
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study 221
A concerted binding study using binding measurements, X-ray structural data and molecular modeling on the stereochemical features responsible for the affinity of 6-arylpyrrolo[2,1-d][1,5]benzothiazepines to mitochondrial benzodiazepine receptors 220
ALTERATION OF ADENOSINE RECEPTORS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 220
A3 adenosine receptors are overexpressed in pleura from patients with mesothelioma and reduce malignant mesothelioma cell growth 219
4-(4-Fluorobenzoyl)-1-[2-(4-iodo-2,5-dimethoxyphenyl)ethyl]piperidine and its derivatives: Synthesis and affinity at 5-HT(2A), 5-HT(2B) and 5- HT(2C) serotonin receptors 219
Current status of A1 adenosine receptor allosteric enhancers 219
van't Hoff Based Thermodynamics 219
Effects of doxazosin and propranolol on A2A adenosine receptors in essential hypertension 217
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells 217
Binding thermodynamics and intrinsic activity of adenosine A1 receptor ligands 217
The Anti-Tumor Effect of A(3) Adenosine Receptors Is Potentiated by Pulsed Electromagnetic Fields in Cultured Neural Cancer Cells 217
Biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptors 217
New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2 216
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 215
P2X1 and P2X3 Purinergic Receptors Differentially Modulate the Inflammatory Response in Human Osteoarthritic Synovial Fibroblasts 215
A2A adenosine receptor upregulation correlates with disease activity in patients with systemic lupus erythematosus 215
Synthesis and pharmacology of 6-substituted benztropines: Discovery of novel dopamine uptake inhibitors possessing low binding affinity to the dopamine transporter 215
Alteration of adenosine receptore in patients with chronic obstructive pulmonary disease 215
Synthesis of a new series of pyrazolo[1,5-a]pyrimidines structurally related to zaleplon 213
[3H]-MRE 2029-F20, a novel selective antagonist radioligand, for the pharmacological and biochemical characterization of A2B receptors. 213
Binding and signaling studies disclose a potential allosteric site for cannabidiol in cannabinoid CB2 receptors 212
Receptor binding at two different temperatures to discriminate agonist and antagonist behaviour of adenosine A1 receptor ligands in rat brain 211
M3 muscarinic receptors in peripheral lung parenchima of patients with chronic obstructive pulmonary disease. 211
Structure-activity relationship studies of a new series of imidazo[2,1-f] purinones as potent and selective A3 adenosine receptor antagonists 211
Novel role for polycystin-1 in modulating cell proliferation through calcium oscillations in kidney cells 211
3H SCH 58261 labelling of functional A2A adenosine receptors in human neutrophil membranes 211
Agonists and antagonists: Molecular mechanisms and therapeutic applications 211
Electrophysiological basis for the enhanced cardiac arrhythmogenic effect of isoprenaline in aged spontaneously hypertensive rats 210
A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cells 210
Microwave-assisted synthesis of thieno[2,3-c]pyridine derivatives as a new series of allosteric enhancers at the adenosine A(1) receptor 210
Targeting A3 and A2A adenosine receptors in the fight against cancer 210
Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonists 209
7-substituted-5-amino-2-(furyl)-pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonists: importance of modifications at the side chain on the activity and solubility. 209
Pathological overproduction: the bad side of adenosine 209
Totale 28.378
Salva come PNG Salva come JPEG
Categoria #
all - tutte 446.763
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 17.084
Totale 463.847
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021460 0 0 0 0 0 0 0 0 0 0 0 460
2021/20226.405 141 667 443 343 406 252 229 321 245 500 823 2.035
2022/20236.799 720 418 200 898 1.133 1.042 273 566 876 53 372 248
2023/20243.370 354 442 175 97 353 386 183 242 66 101 107 864
2024/202513.457 395 383 1.062 633 1.646 1.192 406 904 1.847 1.522 1.911 1.556
2025/202640.645 3.833 1.684 3.942 4.949 5.365 2.610 4.561 1.952 5.516 4.244 1.388 601
Totale 107.807